Publications in collaboration with researchers from Hospital Universitario La Fe (24)

2026

  1. PROA-COMPLEX: redefiniendo los programas de optimización del uso de antimicrobianos para mejorar los resultados clínicos en pacientes de alto riesgo con infecciones graves

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 39, Núm. 3, pp. 191-237

2025

  1. Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC: GEPI, GeSIDA, GESITRA-IC, GEIRAS) on screening for imported infectious diseases in immunocompromised patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 43, Núm. 9, pp. 611-615

  2. Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.

    Transplantation Reviews, Vol. 39, Núm. 3

  3. Utilización de recursos sanitarios y costes asociados al tratamiento antibiótico inicial inadecuado de la bacteriemia producida por bacilos gramnegativos resistentes a carbapenémicos: un estudio observacional descriptivo en hospitales españoles

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 38, Núm. 3, pp. 197-207

2024

  1. How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations

    Enfermedades infecciosas y microbiologia clinica (English ed.), Vol. 42, Núm. 8, pp. 442-452

2022

  1. Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 7, pp. 1996-2002

2020

  1. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

    Frontiers in Immunology, Vol. 11

  2. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 8, pp. 379-389

  3. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus

    Transplantation Reviews, Vol. 34, Núm. 2

2018

  1. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 32, Núm. 1, pp. 36-57

  2. Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

    Clinical Microbiology and Infection, Vol. 24, Núm. 2, pp. 192-198

2017

  1. Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study

    American Journal of Transplantation, Vol. 17, Núm. 5, pp. 1304-1312

  2. Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: Results of TRANSGRIPE 1-2, a randomized controlled clinical trial

    Clinical Infectious Diseases, Vol. 64, Núm. 7, pp. 829-838

2016

  1. Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 11, pp. 3220-3234

  2. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 30, Núm. 3, pp. 119-143

  3. Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study

    American Journal of Transplantation, Vol. 16, Núm. 7, pp. 2148-2157

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

  2. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe

    Clinical Microbiology and Infection, Vol. 21, Núm. 11, pp. 1040.e11-1040.e18

2014

  1. Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: Study protocol for a multicenter, randomized, controlled clinical trial

    Trials, Vol. 15, Núm. 1

2013

  1. How to assist clinicians in improving antimicrobial prescribing: Tools and interventions provided by stewardship programs

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. SUPPL. 4, pp. 38-44